Cohort effects in dynamic models and their impact on vaccination programmes: an example from Hepatitis A
作者： Arni SR Srinivasa Rao , Maggie H Chen , Ba' Z Pham , Andrea C Tricco , Vladimir Gilca
关键词: Demography 、 Incidence (epidemiology) 、 Immunology 、 Cohort study 、 Cohort effect 、 Medical microbiology 、 Hepatitis A vaccine 、 Vaccination 、 Hepatitis A 、 Medicine 、 Seroprevalence
摘要: Background Infection rates for many infectious diseases have declined over the past century. This has created a cohort effect, whereby older individuals experienced higher infection rate in their than younger do now. As result, age-stratified seroprevalence profiles often differ from what would be expected constant rates.
biomedcentral.com
springer.com
elsevier.com
uoguelph.ca
utoronto.ca
paperity.org参考文章(53)
Jay H. Hoofnagle, Jules Dienstag, Girish N. Vyas, Viral Hepatitis and Liver Disease ,(1985)
Susie ElSaadany, Paul Gully, Antonio Giulivi, Hepatitis A, B, and C in Canada. Results from the National Sentinel Health Unit Surveillance System, 1993-1995. Canadian Journal of Public Health-revue Canadienne De Sante Publique. ,vol. 93, pp. 435- 438 ,(2002) , 10.1007/BF03405032
Robert M. May, Roy M. Anderson, Infectious Diseases of Humans: Dynamics and Control ,(1991)
Ba' Pham, Bernard Duval, Gaston De Serres, Vladimir Gilca, Andrea C Tricco, Jan Ochnio, David W Scheifele, Seroprevalence of hepatitis A infection in a low endemicity country: a systematic review. BMC Infectious Diseases. ,vol. 5, pp. 56- 56 ,(2005) , 10.1186/1471-2334-5-56
J. B. Garner, M. D. Crewe, J. A. Embil, Prevalence of antibodies to hepatitis A virus in Nova Scotia children Canadian Medical Association Journal. ,vol. 128, pp. 1195- 1197 ,(1983)
WAYNE M. LEDNAR, STANLEY M. LEMON, JAMES W. KIRKPATRICK, ROBERT R. REDFIELD, MIRIAM L. FIELDS, PATRICK W. KELLEY, FREQUENCY OF ILLNESS ASSOCIATED WITH EPIDEMIC HEPATITIS A VIRUS INFECTIONS IN ADULTS American Journal of Epidemiology. ,vol. 122, pp. 226- 233 ,(1985) , 10.1093/OXFORDJOURNALS.AJE.A114093
Allen S. Craig, William Schaffner, Prevention of Hepatitis A with the Hepatitis A Vaccine New England Journal of Medicine. ,vol. 350, pp. 476- 481 ,(2004) , 10.1056/NEJMCP031540
Piero L. Almasio, Pietro Amoroso, HAV infection in chronic liver disease: a rationale for vaccination Vaccine. ,vol. 21, pp. 2238- 2241 ,(2003) , 10.1016/S0264-410X(03)00139-7
Isabelle Rouleau, Bernard Duval, Ramak Shadmani, Monika Naus, Brian J. Ward, Cathy Gosselin, Gaston De Serres, Comparison of trip characteristics of children and adults with travel-acquired hepatitis A infection. Pediatric Infectious Disease Journal. ,vol. 25, pp. 1184- 1186 ,(2006) , 10.1097/01.INF.0000246852.21859.92
M Sjogren, Acute hepatitis a: An endangered species Werzberger A, Mensch B, Kuter B, Brown L, Lewis J, Sitrin R, Miller W, et al. A controlled trial of formalin-inactivated hepatitis A vaccine in healthy children. N Engl J Med 1992; 327: 453–457 Hepatology. ,vol. 17, pp. 519- 520 ,(1993) , 10.1016/0270-9139(93)90067-W